Richard Staelin, Ph.D. Rejoins the Board of BioElectronics Corporation

FREDERICK, MD, June 15, 2020 (GLOBE NEWSWIRE) —  via NEWMEDIAWIRE – BioElectronics Corporation (OTC: BIEL), www.bielcorp.com, the maker of non-invasive electroceutical devices, announced today that it has appointed Richard Staelin, Ph.D. as the Chairman of the Board following the resignation and retirement of Ms. Patricia Whelan.  “The management team at BioElectronics thanks Patricia Whelan for her […]

BioElectronics Announces FDA Market Clearance for Over-The-Counter Treatment of Musculoskeletal Pain

FREDERICK, MD- February 3, 2020 – BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, the maker of non-invasive electroceutical devices, is pleased to announce that it has obtained a new 510(k) clearance from the U.S. Food and Drug Administration (FDA).  This new, over-the counter marketing clearance was granted for the drug free ActiPatch® medical device, for the […]

BioElectronics ActiPatch Drug Free Pain Therapy Receives United Kingdom National Health System Payment Coverage

FREDERICK, Md., Jan. 04, 2018 (GLOBE NEWSWIRE) — BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com makes wearable, drug-free chronic pain therapy medical devices. It is pleased to announce that the UK’s government funded public health service, National Health System (NHS), has approved our application to cover and pay for ActiPatch® Musculoskeletal Pain Therapy. The NHS estimates that almost half […]

BioElectronics Announces Drug Free Solution to the Opioid Crisis (ActiPatch)

FREDERICK, MD–(Marketwired – Nov 6, 2017) – BioElectronics Corporation ( OTC PINK :BIEL ), the maker of advanced consumer pain management medical device, ActiPatch, today announced that it has taken on the responsibility to find a DRUG-FREE solution to the Opioid Crisis. The reach of the opioid crisis now stretches wide and far, claiming an American life every […]

BioElectronics Announces Independent Back Pain Clinical Study Pulsed Neuromodulation Therapy (ActiPatch) for Chronic Musculoskeletal Lower Back Pain

FREDERICK, MD–(Marketwired – Oct 16, 2017) – BioElectronics Corporation ( OTC PINK : BIEL ), www.bielcorp.com is pleased to announce the commencement of a clinical study investigating the efficacy of ActiPatch in treating chronic musculoskeletal lower back pain. Low back pain is highly prevalent and affects 1 in 3 adult Americans, accounting for about $ 90 billion in direct spending every […]

BioElectronics Completes Subject Enrollment for Migraine Clinical Study; Migraine Prevention Using ActiPatch (Neuromodulation Therapy)

FREDERICK, MD–(Marketwired – Sep 25, 2017) –  BioElectronics Corporation ( OTC PINK : BIEL ), www.bielcorp.com is pleased to report on the progress of its Migraine prevention clinical study. The randomized, double-blinded, sham-controlled study involving 48 subjects is designed to investigate if ActiPatch therapy can be used to prevent the frequency and intensity of migraine attacks. Since receiving IRB-approval for the […]

Letter from BioElectronics’ (OTC PINK: BIEL) President to Investors

FREDERICK, MD–(Marketwired – Aug 28, 2017) – The following is a statement from BioElectronics ( OTC PINK : BIEL ). Dear Fellow Shareholders, These are busy and exciting times at BioElectronics ( OTC PINK : BIEL ). New Product Opportunities Over the last few years, there have been two significant developments: 1) There has been a paradigm shift in the medical community’s understanding of how […]

BioElectronics’ President Discusses Company’s Many Opportunities

FREDERICK, MD–(Marketwired – Aug 22, 2017) – The following is a statement from BioElectronics ( OTC PINK : BIEL ). Dear Fellow Shareholders, These are busy and exciting times at BioElectronics. New Product Opportunities Over the last few years, there have been two significant developments: 1) There has been a paradigm shift in the medical community’s understanding of how […]

BioElectronics Engages Keith Nalepka As Vice President of Sales and Marketing

FREDERICK, MD–(Marketwired – Aug 22, 2017) –  BioElectronics Corporation ( OTC PINK : BIEL ), the maker of advanced consumer pain management medical devices, today announced that it has engaged Keith Nalepka as the Vice President of Sales and Marketing. Keith has over 15 years of experience working in the retail sales industry, both with large multi-million dollar brands […]

BioElectronics Announces Update on Migraine Clinical Study Migraine Prevention Using ActiPatch (Neuromodulation Therapy)

FREDERICK, MD–(Marketwired – Aug 8, 2017) – BioElectronics Corporation ( OTC PINK :BIEL ), www.bielcorp.com is pleased to report on the progress of its Migraine prevention clinical study. The randomized, double-blinded, sham-controlled study involving 48 subjects is designed to investigate if ActiPatch therapy can be used to prevent the frequency and intensity of migraine attacks. Since receiving IRB-approval for the […]